SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
19397460
Source:
http://linkedlifedata.com/resource/pubmed/id/19397460
Search
Subject
(
58
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0013227
,
umls-concept:C0019693
,
umls-concept:C0030705
,
umls-concept:C0041296
,
umls-concept:C0205179
,
umls-concept:C0360390
,
umls-concept:C1720825
,
umls-concept:C2919063
pubmed:issue
5
pubmed:dateCreated
2009-4-28
pubmed:abstractText
To determine the feasibility of therapeutic drug monitoring for adjusting low serum antimycobacterial concentrations in patients with both tuberculosis and advanced human immunodeficiency virus (HIV).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8111305
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Retroviral Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Isoniazid
,
http://linkedlifedata.com/resource/pubmed/chemical/Rifabutin
,
http://linkedlifedata.com/resource/pubmed/chemical/Rifampin
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1875-9114
pubmed:author
pubmed-author:EngemannJohn JJJ
,
pubmed-author:FortenberryEllen RER
,
pubmed-author:HamiltonCarol DCD
,
pubmed-author:HollandDavid PDP
,
pubmed-author:PeloquinCharles ACA
,
pubmed-author:StoutJason EJE
,
pubmed-author:WeintrobAmy CAC
pubmed:issnType
Electronic
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
503-10
pubmed:meshHeading
pubmed-meshheading:19397460-Adult
,
pubmed-meshheading:19397460-Aged
,
pubmed-meshheading:19397460-Anti-Bacterial Agents
,
pubmed-meshheading:19397460-Anti-Retroviral Agents
,
pubmed-meshheading:19397460-Cohort Studies
,
pubmed-meshheading:19397460-Drug Monitoring
,
pubmed-meshheading:19397460-Drug Therapy, Combination
,
pubmed-meshheading:19397460-Feasibility Studies
,
pubmed-meshheading:19397460-Female
,
pubmed-meshheading:19397460-HIV Infections
,
pubmed-meshheading:19397460-Humans
,
pubmed-meshheading:19397460-Isoniazid
,
pubmed-meshheading:19397460-Male
,
pubmed-meshheading:19397460-Middle Aged
,
pubmed-meshheading:19397460-Retrospective Studies
,
pubmed-meshheading:19397460-Rifabutin
,
pubmed-meshheading:19397460-Rifampin
,
pubmed-meshheading:19397460-Tuberculosis
pubmed:year
2009
pubmed:articleTitle
Therapeutic drug monitoring of antimycobacterial drugs in patients with both tuberculosis and advanced human immunodeficiency virus infection.
pubmed:affiliation
Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
pubmed:publicationType
Journal Article
,
Research Support, Non-U.S. Gov't